Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall

Pathobiology

Volumn 76, Issue 5, 2009, Pages 243-252

  Reeps, Christian ^a   Pelisek, Jaroslav ^a   Seidl, Stefan ^b   Schuster, Tibor ^c   Zimmermann, Alexander ^a   Kuehnl, Andreas ^a   Eckstein, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Institute of Pathology   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aneurysm; Inflammation; Matrix metalloproteinases; Neovascularization

Indexed keywords

COLLAGEN; COLLAGENASE 3; ELASTIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA MEDIA; AORTA WALL; ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MONOCYTE; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); ORGAN DONOR; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; COLLAGEN; ELASTIN; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC;

EID: 70449115998     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228900     Document Type: Article

References (33)

1. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, Thompson MM: A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005; 30: 227-244.
2. Kniemeyer HW, Kessler T, Reber PU, Ris HB, Hakki H, Widmer MK: Treatment of ruptured abdominal aortic aneurysm, a permanent challenge or a waste of resources? Prediction of outcome using a multi-organdysfunction score. Eur J Vasc Endovasc Surg 2000; 19: 190-196.
3. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006; 26: 987-994.
4. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503.
5. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML: An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005; 39: 457-464.
6. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PRF: Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1996; 11: 464-469.
7. Thompson MM: Controlling the expansion of abdominal aortic aneurysms. Br J Surg 2003; 90: 897-898.
8. Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM, Cockerill GW: Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 2006; 26: 2077-2082.
9. Sakalihasan N, Limet R, Defawe OD: Abdominal aortic aneurysm. Lancet 2005; 365: 1577-1589.
10. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 1997; 96: 2228-2232.
11. Papalambros E, Sigala F, Georgopoulos S, Menekakos C, Giatromanolaki A, Bastounis E, Sivridis E: Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: Correlation with symptoms and aortic diameter. Int J Mol Med 2003; 12: 965-968.
12. Petersen E, Gineitis A, Wagberg F, Angquist KA: Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg 2000; 20: 457-461.
13. Petersen E, Wagberg F, Angquist KA: Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg 2002; 23: 153-157.
14. Wilson WR, Schwalbe EC, Jones JL, Bell PR, Thompson MM: Matrix metalloproteinase 8 in the pathogenesis of abdominal aortic aneurysm. Br J Surg 2005; 92: 828-833.
15. Wilson WR, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PR, Thompson MM: MMP-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 2006; 113: 438-445.
16. Kazi M, Zhu C, Roy J, Paulsson-Berne G, Hamsten A, Swedenborg J, Hedin U, Eriksson P: Difference in matrix-degrading protease expression and activity between thrombus- free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2005; 25: 1341-1346.
17. Kobayashi M, Matsubara J, Matsushita M, Nishikimi N, Sakurai T, Nimura Y: Expression of angiogenesis and angiogenic factors in human aortic vascular disease. J Surg Res 2002; 106: 239-245.
18. Paik DC, Fu C, Bhattacharya J, Tilson MD: Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp Mol Med 2004; 36: 524-533.
19. Vorp DA, Lee PC, Wang DH, Makaroun MS, Nemoto EM, Ogawa S, Webster MW: Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001; 34: 291-299.
20. Lindholt JS, Shi GP: Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2006; 31: 453-463.
21. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999; 99: 96-104.
22. Pearce WH, Koch AE: Cellular components and features of immune response in abdominal aortic aneurysms. Ann NY Acad Sci 1996; 800: 175-185.
23. Bobryshev YV, Lord RS, Parsson H: Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg 1998; 6: 240-249.
24. Forester ND, Cruickshank SM, Scott DJ, Carding SR: Functional characterization of T cells in abdominal aortic aneurysms. Immunology 2005; 115: 262-270.
25. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85: 1-31.
26. World Medical Association Declaration of Helsinki. Cardiovasc Res 1997; 35: 2-3.
27. Schönbeck U, Mach F, Sukhova GK, Atkinson E, Levesque E, Herman M, Graber P, Basset P, Libby P: Expression of stromelysin- 3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med 1999; 189: 843-853.
28. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
29. Lemaitre V, D'Armiento J: Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78: 1-10.
30. Newby AC: Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006; 69: 614-624.
31. Dollery CM, Libby P: Atherosclerosis and proteinase activation. Cardiovasc Res 2006; 69: 625-635.
32. Galis ZS, Sukhova GK, Kranzhöfer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995; 92: 402-406.
33. Vogel CF, Sciullo E, Matsumura F: Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc Toxicol 2004; 4: 363-373.